We delve into the implications of the recent study published in JAMA Internal Medicine, exposing how older risk models overestimate cardiovascular risk by about 50%. This overestimation has profound implications for primary statin use, insurer policies, and regulatory practices. Our discussion highlights the need for updated guidelines that reflect the most current evidence, ensuring better patient care and aligning clinical practice with the latest scientific findings.

The GameChanger: Adopting the PREVENT equations could significantly refine statin prescriptions, ensuring millions of adults receive appropriate cardiovascular risk management.

Upon successful completion of this course, learners should be able to:
1. Discuss the impact of the PREVENT equations on statin prescription recommendations for cardiovascular disease prevention.
2. Explain clinical implications and practice changes from integrating the PREVENT equations into cardiovascular risk guidelines.

Guests
Geoffrey C. Wall, PharmD, FCCP, BCPS, CG
Professor of Clinical Sciences
Drake University College of Pharmacy and Health Sciences

Jake Galdo, PharmD, MBA, BCPS, BCGP
CEO
Seguridad

Dr. Wall is a member of the Janssen Speaker’s Bureau. All relevant financial relationships have been mitigated.
Dr. Galdo’s spouse is an employee of Eli Lilly. All relevant financial relationships have been mitigated.

Course fee includes course, course materials, and CPE credit submission to CPE Monitor.
Course is non-refundable.
Release Date: August 12, 2024
Planned Expiration Date: August 12, 2025

Copyright 2024, CEimpact. All Rights Reserved. Any reproduction of this course without express permission is strictly forbidden.